Press Releases

The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce, further to …

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division Read More »

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, has …

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Read More »

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FRA: 5NP) (FSE: 5NP)  (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that industry veteran Jenna Pozar …

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer Read More »

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience and technology leader HealthTech Connex Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce …

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc. Read More »

The acquisition is intended to vertically integrate the Company’s retail manufacturing capabilities to support the growth of its nutraceutical division and deliver unique products to consumers. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division Read More »